PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
FMED vs. XLV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


FMEDXLV
YTD Return7.36%8.88%
1Y Return23.40%16.65%
Sharpe Ratio1.721.66
Sortino Ratio2.472.33
Omega Ratio1.301.30
Calmar Ratio1.552.11
Martin Ratio7.557.20
Ulcer Index3.58%2.42%
Daily Std Dev15.73%10.50%
Max Drawdown-21.84%-39.18%
Current Drawdown-2.13%-6.27%

Correlation

-0.50.00.51.00.7

The correlation between FMED and XLV is 0.71, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

FMED vs. XLV - Performance Comparison

In the year-to-date period, FMED achieves a 7.36% return, which is significantly lower than XLV's 8.88% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-4.00%-2.00%0.00%2.00%4.00%6.00%8.00%JuneJulyAugustSeptemberOctoberNovember
5.53%
1.20%
FMED
XLV

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


FMED vs. XLV - Expense Ratio Comparison

FMED has a 0.50% expense ratio, which is higher than XLV's 0.12% expense ratio.


FMED
Fidelity Disruptive Medicine ETF
Expense ratio chart for FMED: current value at 0.50% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.50%
Expense ratio chart for XLV: current value at 0.12% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.12%

Risk-Adjusted Performance

FMED vs. XLV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Disruptive Medicine ETF (FMED) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


FMED
Sharpe ratio
The chart of Sharpe ratio for FMED, currently valued at 1.72, compared to the broader market-2.000.002.004.001.72
Sortino ratio
The chart of Sortino ratio for FMED, currently valued at 2.47, compared to the broader market0.005.0010.002.47
Omega ratio
The chart of Omega ratio for FMED, currently valued at 1.30, compared to the broader market1.001.502.002.503.001.30
Calmar ratio
The chart of Calmar ratio for FMED, currently valued at 1.55, compared to the broader market0.005.0010.0015.001.55
Martin ratio
The chart of Martin ratio for FMED, currently valued at 7.55, compared to the broader market0.0020.0040.0060.0080.00100.00120.007.55
XLV
Sharpe ratio
The chart of Sharpe ratio for XLV, currently valued at 1.66, compared to the broader market-2.000.002.004.001.66
Sortino ratio
The chart of Sortino ratio for XLV, currently valued at 2.33, compared to the broader market0.005.0010.002.33
Omega ratio
The chart of Omega ratio for XLV, currently valued at 1.30, compared to the broader market1.001.502.002.503.001.30
Calmar ratio
The chart of Calmar ratio for XLV, currently valued at 2.76, compared to the broader market0.005.0010.0015.002.76
Martin ratio
The chart of Martin ratio for XLV, currently valued at 7.20, compared to the broader market0.0020.0040.0060.0080.00100.00120.007.20

FMED vs. XLV - Sharpe Ratio Comparison

The current FMED Sharpe Ratio is 1.72, which is comparable to the XLV Sharpe Ratio of 1.66. The chart below compares the historical Sharpe Ratios of FMED and XLV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00JulyAugustSeptemberOctoberNovember
1.72
1.66
FMED
XLV

Dividends

FMED vs. XLV - Dividend Comparison

FMED has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 1.55%.


TTM20232022202120202019201820172016201520142013
FMED
Fidelity Disruptive Medicine ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XLV
Health Care Select Sector SPDR Fund
1.55%1.59%1.47%1.33%1.49%2.17%1.58%1.47%1.60%1.43%1.35%1.52%

Drawdowns

FMED vs. XLV - Drawdown Comparison

The maximum FMED drawdown since its inception was -21.84%, smaller than the maximum XLV drawdown of -39.18%. Use the drawdown chart below to compare losses from any high point for FMED and XLV. For additional features, visit the drawdowns tool.


-8.00%-6.00%-4.00%-2.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-2.13%
-6.27%
FMED
XLV

Volatility

FMED vs. XLV - Volatility Comparison

Fidelity Disruptive Medicine ETF (FMED) has a higher volatility of 3.37% compared to Health Care Select Sector SPDR Fund (XLV) at 2.87%. This indicates that FMED's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%JuneJulyAugustSeptemberOctoberNovember
3.37%
2.87%
FMED
XLV